Search for Clinical Trial Results

Adrenal Cortex Diseases - 13 Studies Found

Status Study
Completed Study Name: Adrenal Responsiveness During the Perioperative Period in Children Undergoing Congenital Cardiac Surgery
Condition:
  • Adrenal Cortex Diseases
  • Infant Morbidity

Date: 2013-04-22
Interventions: Drug: Cosyntropin A cosyntropin stimulation test is administered to each patient at 3 time points during
Not yet recruiting Study Name: Expression of Different Proliferation Biomarkers in Adreno-cortical Tumors
Condition:
  • Adrenal Cortex Neoplasms
  • Adrenal Cortex Diseases

Date: 2016-04-19
Not yet recruiting Study Name: The Effects of Case Management in a Medicaid Managed Care Plan
Condition:
  • Neoplasms
  • Heart Diseases
  • Adrenal Cor
    Date: 2006-10-09
    Interventions: Behavioral: Case management
Completed Study Name: Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-Pathway in Metastatic, Recurrent or Primary Unresectable Adrenocortical Cancer
Condition: Adrenal Cortex Neoplasms
Date: 2010-12-04
Interventions: Drug: Axitinib 5 mg tab orally twice a day with food every 28 days
Completed Study Name: International Pediatric Adrenocortical Tumor Registry
Condition: Adrenocortical Tumor
Date: 2008-06-13
Completed Study Name: Surgery Plus Chemotherapy (Doxorubicin, Vincristine and Etoposide), Mitotane, and Tariquidar to Treat Adrenocortical Cancer
Condition: Adrenal Cortex Neoplasms
Date: 2003-10-09
Interventions: Drug: XR9576 (Tariquidar) Other Name: 150 mg tariquidar through central venous catheter over 30 minutes
Active, not recruiting Study Name: Activity of Abiraterone Acetate in the Management of Cushing's Syndrome in Patients With Adrenocortical Carcinoma
Condition:
  • Cushing Syndrome
  • Adrenocortical Carcinoma

Date: 2017-04-26
Interventions: Drug: Abiraterone Acetate Cohort 1:
Not yet recruiting Study Name: Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma
Condition:
  • Adrenocortical Carcinoma
  • Peritoneal Carcinomatosis

Date: 2017-04-02
Interventions:
  • Drug: Cisplatin

Not yet recruiting Study Name: Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Condition:
  • Adrenal Cortex Carcinoma
  • Adult Alveolar Soft Part Sarcoma

  • Date: 2016-08-15
    Interventions:
    • Drug: Cabozantinib S-malate Gi
Not yet recruiting Study Name: Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor
Condition:
  • Functional Pancreatic Neuroendocrine Tumor
  • Malignant Somatostatinoma
  • Drug: Capecitabine Given PO
Next >>>